Pharmacological treatment of Parkinson disease: a review.

@article{Connolly2014PharmacologicalTO,
  title={Pharmacological treatment of Parkinson disease: a review.},
  author={Barbara S. Connolly and A. Lang},
  journal={JAMA},
  year={2014},
  volume={311 16},
  pages={
          1670-83
        }
}
IMPORTANCE Parkinson disease is the second most common neurodegenerative disease worldwide. [...] Key MethodEVIDENCE REVIEW References were identified using searches of PubMed between January 1985 and February 2014 for English-language human studies and the full database of the Cochrane Library. The classification of studies by quality (classes I-IV) was assessed using the levels of evidence guidelines from the American Academy of Neurology and the highest-quality data for each topic. Expand
Treating the Motor Symptoms of Parkinson Disease
Initial management of Parkinson’s disease
Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis
Treatment of Older Parkinson's Disease.
Emerging Pharmacotherapies for Motor Symptoms in Parkinson’s Disease
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 161 REFERENCES
Impact of standard of care for psychosis in Parkinson disease
Management of hallucinations and psychosis in Parkinson's disease.
  • M. Eng, T. Welty
  • Medicine
  • The American journal of geriatric pharmacotherapy
  • 2010
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
...
1
2
3
4
5
...